These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38494042)

  • 1. Review of the standards of proof (of safety) for FDA regulated consumer products and how the generally recognized as safe criteria could be applied to cosmetics.
    Burdock GA
    Regul Toxicol Pharmacol; 2024 May; 149():105603. PubMed ID: 38494042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time for a makeover-cosmetics regulation in the United States.
    Cornell EM; Janetos TM; Xu S
    J Cosmet Dermatol; 2019 Dec; 18(6):2041-2047. PubMed ID: 30950176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Assessment of Alumina and Aluminum Hydroxide as Used in Cosmetics.
    Becker LC; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):16S-33S. PubMed ID: 27913785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalls of foods and cosmetics due to microbial contamination reported to the U.S. Food and Drug Administration.
    Wong S; Street D; Delgado SI; Klontz KC
    J Food Prot; 2000 Aug; 63(8):1113-6. PubMed ID: 10945589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Assessment of Dialkyl Sulfosuccinate Salts as Used in Cosmetics.
    Fiume MM; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):34S-46S. PubMed ID: 27913786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 9. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hard look at FDA's review of GRAS notices.
    Roberts A; Haighton LA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 2():S124-8. PubMed ID: 27318099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Assessment of Achillea millefolium as Used in Cosmetics.
    Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):5S-15S. PubMed ID: 27913788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective on the safety of cosmetic products: a position paper of the American Council on Science and Health.
    Ross G
    Int J Toxicol; 2006; 25(4):269-77. PubMed ID: 16815815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Assessment of Polyquaternium-22 and Polyquarternium-39 as Used in Cosmetics.
    Johnson W; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2016 Nov; 35(3 suppl):47S-53S. PubMed ID: 27913787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act.
    Nguyen HP; Bergfeld WF; Forman HP; Belsito DV; Bolognia JL
    J Am Acad Dermatol; 2018 Aug; 79(2):403-405. PubMed ID: 29625132
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of ingredients used in cosmetics.
    Bergfeld WF; Belsito DV; Marks JG; Andersen FA
    J Am Acad Dermatol; 2005 Jan; 52(1):125-32. PubMed ID: 15627090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounding botanicals: a legal perspective.
    Valentino JG; Bormel FG
    J Am Pharm Assoc (Wash); 1999; 39(4):537-44. PubMed ID: 10467820
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.